Back to results
US 2011/0236899 A1Published application
Method and Apparatus for Predicting Pharmaceutical Efficacy of Anti-TNFa Antibody Drug Against Rheumatoid Arthritis
OwnerKensei Tsuzaka, Tsutomu Takeuchiinventors
Life of this patent
Estimating the term…
Abstract
A method for predicting a pharmaceutical efficacy of an anti-TNFα antibody drug against rheumatoid arthritis, the method including measuring an amount of ADAMTS5 contained in a sample derived from a subject, and determining whether or not the anti-TNFα antibody drug is efficient against rheumatoid arthritis by employing the amount of ADAMTS5 as an index.
Claims12
A method for predicting a pharmaceutical efficacy of an anti-TNFα antibody drug against rheumatoid arthritis, the method comprising:
- measuring an amount of ADAMTS5 contained in a sample derived from a subject, and
- determining whether or not the anti-TNFα antibody drug is efficient against rheumatoid arthritis by employing the amount of ADAMTS5 as an index.
An apparatus for predicting a pharmaceutical efficacy of an anti-TNFα antibody drug against rheumatoid arthritis, the apparatus comprising:
- a unit configured to measure an amount of ADAMTS5 contained in a sample derived from a subject, and
- a unit configured to determine whether or not the anti-TNFα antibody drug is efficient against rheumatoid arthritis by employing the amount of ADAMTS5 as an index.
Dependencies are inferred from the claim text.